Antifungal prophylaxis of COVID-19 associated pulmonary aspergillosis in ventilated patients: one solution does not fit all

Intensive Care Med. 2024 Aug;50(8):1375-1377. doi: 10.1007/s00134-024-07542-0. Epub 2024 Jul 9.

Juergen Prattes^#^{1

2}, Daniele R Giacobbe^#^{3

4}, Matteo Bassetti^#^{3

4}, Jean-Pierre Gangneux^#^{5

6}, Martin Hoenigl^#^{7

8}; POSACOVID Study Group

POSACOVID Study Group:
Cristina Marelli, Alessio Signori, Silvia Dettori, Greta Cattardico, Jonas Frost, Florian Reizine

¹ Department of Internal Medicine, Division of Infectious Diseases, Excellence Centre for Medical Mycology (ECMM), Medical University of Graz, Auenbruggerplatz 15, 8036, Graz, Austria. juergen.prattes@medunigraz.at.
² BioTechMed Graz, Graz, Austria. juergen.prattes@medunigraz.at.
³ Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.
⁴ Clinica Malattie Infettive, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
⁵ EHESP, Irset (Institut de Recherche en Santé, Environnement Et Travail)-UMR_S 1085, CHU Rennes, Inserm, Univ Rennes, 35000, Rennes, France.
⁶ Laboratoire de Parasitologie-Mycologie, Centre National de Référence Pour Les Aspergilloses Chroniques (CNRMA-LA AspC), ECMM Excellence Center for Medical Mycology, Centre Hospitalier Universitaire de Rennes, Rennes, France.
⁷ Department of Internal Medicine, Division of Infectious Diseases, Excellence Centre for Medical Mycology (ECMM), Medical University of Graz, Auenbruggerplatz 15, 8036, Graz, Austria.
⁸ BioTechMed Graz, Graz, Austria.

^# Contributed equally.

No abstract available

Publication types